Target intelligence / Profile preview

RNA, U6 small nuclear 328, pseudogene (RNU6-328P)

Target
RNU6-328P
Molecular classification
Other, Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNA, U6 small nuclear 328, pseudogene (RNU6-328P) is a non-coding pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential component of the spliceosome, which catalyzes the removal of introns from pre-mRNA in eukaryotic cells[1][3]. However, RNU6-328P is classified as a pseudogene, meaning it is a genomic DNA sequence resembling the functional U6 snRNA gene but is generally believed to be nonfunctional, neither encoding a functional RNA nor a protein[5]. Pseudogenes may arise through gene duplication or retrotransposition events and often accumulate mutations that incapacitate their function. Although most pseudogenes, including U6-derived ones, do not have a direct biological function, some pseudogenes in general can generate small RNAs and may modulate the expression of related genes via RNA interference or competitive binding to microRNAs (miRNA sponging), potentially affecting cellular function or disease phenotypes[4]. There is no evidence that RNU6-328P itself is a therapeutic target, nor are there drugs, disease associations, or clinical biomarkers directly referencing this pseudogene. The detailed sequence and structuring of U6 snRNA pseudogenes have been described, illustrating their evolutionary derivation from authentic U6 snRNA sequences but with loss of canonical activity[5].

Other names
RNU6-328PU6 snRNA pseudogene 328U6 small nuclear RNA pseudogene 328
02

Biological functions

Typically none (pseudogenes are generally non-functional)some pseudogenes may regulate gene expression via RNA-mediated mechanisms (e.g., as competing endogenous RNAs, ceRNAs)[4]
03

Disease associations

Usually none directly attributed, but some pseudogenes have been implicated as regulators or biomarkers in cancer and other diseases through RNA-based regulatory functions[4]. No specific disease association for RNU6-328P is documented.

Beyond the preview

Go deeper on RNA, U6 small nuclear 328, pseudogene (RNU6-328P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 328, pseudogene (RNU6-328P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call